Richard completed his PhD in Molecular Biology & Bioinformatics at the University of Barcelona, where he developed computational methods to elucidate gene-regulatory networks in pancreatic neuroendocrine tumours. Prior to this he worked in human genetics at the Sanger Institute and molecular genetics in the NHS. Richard is working on Therapeutic targeting of refractory relapsed diffuse large B-cell lymphoma through systems biology with funding from a UKRI Future Leaders Fellowship.

  • Systems biology
  • Bioinformatics
  • Regulatory genomics
  • Gene expression
  • Molecular basis of disease
  • Cell signalling